Software Effective Solutions Corp. (SFWJ) Joins Others in Applauding Decision to Reschedule Cannabis
- Company calls rescheduling a “monumental decision” that signifies a significant shift in U.S. drug policy
- MedCana CEO notes rescheduling “opens the door to further research, innovation and accessibility, signaling a new era of acceptance and understanding”
- SFWJ remains committed to advancing the dialogue around cannabis policy and supporting initiatives that promote responsible access and use
Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ) has noted a “historic milestone” as the U.S. Drug Enforcement Administration (“DEA”) moves to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act (https://nnw.fm/cQBgr). The company released an announcement from CEO Jose Gabriel Diaz and observed that the “monumental decision,” based on recommendations from the U.S. Department of Health and Human Services, signifies a significant shift in U.S. drug policy.
“The DEA’s decision to reclassify cannabis is a watershed moment in our nation’s drug policy,” said Diaz. “It opens the door to further research, innovation and accessibility, signaling a new era of acceptance and understanding. MedCana is proud to be part of an industry that advocates for sensible cannabis regulation and equitable access to this vital medicine.”
MedCana joined many companies in responding to the proposed reclassification. “Many applauded the move to Schedule III from Schedule I, which the Associated Press first reported and was later confirmed by a Department of Justice spokesperson in a statement to Cannabis Business Times,” reported the Cannabis Business Times (https://nnw.fm/Tw7Ig). “Executives from plant-touching companies noted its significance as a historic step toward federal cannabis reform, destigmatization, fairer tax policies for businesses and more research into cannabis’s medical benefits.
“However, many also tempered the celebratory tone and said that there was much more work to be done,” the article continued. “Leaders from industry nonprofit organizations and some lawmakers emphasized their call for the federal government to deschedule cannabis altogether, something they urged after news circulated that the U.S. Department of Health and Human Services (‘HHS’) recommended that the DEA reschedule cannabis in August 2023.”
While there may be work left to do, the initial rescheduling is certainly noteworthy. The announcement from MedCana noted that cannabis has been unjustly categorized as a Schedule I substance alongside heroin and LSD for more than four decades. This was despite the fact that the substance has recognized medical benefits and low potential for abuse. The DEA’s move to reschedule cannabis — a move that will now undergo a period of public comment — is a clear indication of its therapeutic value and aligns with evolving attitudes toward cannabis policy.
In its announcement, MedCana stated that it remains committed to advancing the dialogue around cannabis policy and supporting initiatives that promote responsible use and access to quality cannabis products.
Operating under Software Effective Solutions Corp., MedCana is a pioneer in the integration of technology and agriculture, focusing on the cannabis market and emerging technologies in agriculture. With a vision to revolutionize the industry through innovation, MedCana is dedicated to acquiring and partnering with companies that align with its mission of promoting sustainable and technologically advanced agricultural practices.
For more information, visit the company’s website at www.MedCana.net.
NOTE TO INVESTORS: The latest news and updates relating to SFWJ are available in the company’s newsroom at https://nnw.fm/SFWJ
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
- Company calls rescheduling a “monumental decision” that signifies a significant shift in U.S. drug policy
- MedCana CEO notes rescheduling “opens the door to further research, innovation and accessibility, signaling a new era of acceptance and understanding”
- SFWJ remains committed to advancing the dialogue around cannabis policy and supporting initiatives that promote responsible access and use
Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ) has noted a “historic milestone” as the U.S. Drug Enforcement Administration (“DEA”) moves to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act (https://nnw.fm/cQBgr). The company released an announcement from CEO Jose Gabriel Diaz and observed that the “monumental decision,” based on recommendations from the U.S. Department of Health and Human Services, signifies a significant shift in U.S. drug policy.
“The DEA’s decision to reclassify cannabis is a watershed moment in our nation’s drug policy,” said Diaz. “It opens the door to further research, innovation and accessibility, signaling a new era of acceptance and understanding. MedCana is proud to be part of an industry that advocates for sensible cannabis regulation and equitable access to this vital medicine.”
MedCana joined many companies in responding to the proposed reclassification. “Many applauded the move to Schedule III from Schedule I, which the Associated Press first reported and was later confirmed by a Department of Justice spokesperson in a statement to Cannabis Business Times,” reported the Cannabis Business Times (https://nnw.fm/Tw7Ig). “Executives from plant-touching companies noted its significance as a historic step toward federal cannabis reform, destigmatization, fairer tax policies for businesses and more research into cannabis’s medical benefits.
“However, many also tempered the celebratory tone and said that there was much more work to be done,” the article continued. “Leaders from industry nonprofit organizations and some lawmakers emphasized their call for the federal government to deschedule cannabis altogether, something they urged after news circulated that the U.S. Department of Health and Human Services (‘HHS’) recommended that the DEA reschedule cannabis in August 2023.”
While there may be work left to do, the initial rescheduling is certainly noteworthy. The announcement from MedCana noted that cannabis has been unjustly categorized as a Schedule I substance alongside heroin and LSD for more than four decades. This was despite the fact that the substance has recognized medical benefits and low potential for abuse. The DEA’s move to reschedule cannabis — a move that will now undergo a period of public comment — is a clear indication of its therapeutic value and aligns with evolving attitudes toward cannabis policy.
In its announcement, MedCana stated that it remains committed to advancing the dialogue around cannabis policy and supporting initiatives that promote responsible use and access to quality cannabis products.
Operating under Software Effective Solutions Corp., MedCana is a pioneer in the integration of technology and agriculture, focusing on the cannabis market and emerging technologies in agriculture. With a vision to revolutionize the industry through innovation, MedCana is dedicated to acquiring and partnering with companies that align with its mission of promoting sustainable and technologically advanced agricultural practices.
For more information, visit the company’s website at www.MedCana.net.
NOTE TO INVESTORS: The latest news and updates relating to SFWJ are available in the company’s newsroom at https://nnw.fm/SFWJ
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
